The Cytochrome P450 OxyD from the balhimycin glycopeptide antibiotic biosynthetic operon of Amycolatopsis mediterranei is involved in the biosynthesis of the modified amino acid -R-hydroxytyrosine, an essential precursor for biosynthesis of the vancomycintype aglycone. OxyD binds the substrate tyrosine not free in solution, but rather covalently linked to the carrier protein (CP) domain of the non-ribosomal peptide synthase BpsD, exhibiting micromolar binding affinity to a tyrosine-loaded carrier protein construct. The crystal structure of OxyD was determined to 2.1 Å resolution, revealing a potential binding site for the carrier protein bound substrate in a different orientation to that seen with the acyl carrier protein-bound P450 BioI (1). A series of residues were identified across known aminoacyl-CP oxidizing P450s that are highly conserved and cluster in the active site or potential CP binding site of OxyD. These residues appear to be characteristic for amino acyl-CP oxidizing P450s, allowing sequence based identification of P450 function for this subgroup of P450s that play vital roles in the biosyntheses of many important natural products in addition to the vancomycin-type antibiotics. The ability to analyze such P450 function based upon sequence data alone should prove an important tool in the analysis and identification of new medicinally relevant biomolecules.
The Cytochrome P450 OxyD from the balhimycin glycopeptide antibiotic biosynthetic operon of Amycolatopsis mediterranei is involved in the biosynthesis of the modified amino acid -R-hydroxytyrosine, an essential precursor for biosynthesis of the vancomycintype aglycone. OxyD binds the substrate tyrosine not free in solution, but rather covalently linked to the carrier protein (CP) domain of the non-ribosomal peptide synthase BpsD, exhibiting micromolar binding affinity to a tyrosine-loaded carrier protein construct. The crystal structure of OxyD was determined to 2.1 Å resolution, revealing a potential binding site for the carrier protein bound substrate in a different orientation to that seen with the acyl carrier protein-bound P450 BioI (1) . A series of residues were identified across known aminoacyl-CP oxidizing P450s that are highly conserved and cluster in the active site or potential CP binding site of OxyD. These residues appear to be characteristic for amino acyl-CP oxidizing P450s, allowing sequence based identification of P450 function for this subgroup of P450s that play vital roles in the biosyntheses of many important natural products in addition to the vancomycin-type antibiotics. The ability to analyze such P450 function based upon sequence data alone should prove an important tool in the analysis and identification of new medicinally relevant biomolecules.
Hydroxylated amino acid residues are widely utilized in Nature as precursors for complex natural products (Fig. 1) . The oxidative modification of amino acids at the -position is a process that occurs in many different classes of medicinally important biomolecules, including the vancomycin-type antibiotics (reviewed in (2, 3) ). These glycopeptide antibiotics have had great clinical success in treating Gram-positive bacterial infections that are resistant to other classes of antibiotics, and function through blocking cell wall biosynthesis via complex formation with the cell wall precursor peptidoglycan peptidyl units terminating in -Lys-D-Ala-D-Ala (2, 3) . The biosynthesis of the vancomycin peptide requires the incorporation of two amino acid residues derived from -R-hydroxytyrosine. Another group of medicinally important molecules that contain hydroxylated amino acid residues is the aminocoumarin containing angucycline family of antibiotic compounds, which include coumermycin A, clorobiocin and simocyclinone and act upon bacterial DNA gyrase.-R-hydroxytyrosine is an essential precursor in the biosynthesis of these type of antibiotics, where it is needed for the formation of both the A (Fig. 1, blue) and B rings (Fig. 1 , red) in the aminocoumarin core. Further examples of the incorporation of hydroxylated amino acids into the biosyntheses of medicinally important compounds can be found in the biosyntheses of the nikkomycin-type antibiotics, zorbamycin and echinomycin ( Fig. 1) (4-7) . Despite the large structural difference in the compounds highlighted above and the difference in the biosyntheses of the compounds overall, the formation of the -hydroxyamino acid precursors follows a conserved route. This involves the oxidation of the amino acid by a member of the Cytochrome P450 (P450) superfamily. P450s form a superfamily of heme containing monoxygenases that catalyze a vast array of biologically important transformations (8) . The archetypical P450 reaction is the hydroxylation of unactivated C-H bonds, a difficult oxidation made more impressive by the ability of P450s to utilize their oxidative power both regio-and stereoselectively. Many P450s play important roles in natural product biosyntheses, where such selectivity is channeled towards the synthesis of complex secondary metabolites. P450s can catalyse a variety of different reactions, including epoxidation of double bonds, heteroatom oxidation, phenolic coupling and multi-step oxidative transformations (9) . The formation of -hydroxy amino acid precursors by P450s differs from the majority of P450-catalyzed oxidation reactions in that the substrate is presented to the P450 in a carrier protein bound form, rather than free in solution. P450s that utilize carrier protein bound substrates form a small but significant subgroup of the superfamily. One example is P450 BioI , which is responsible for the carbon-carbon bond cleavage of acyl carrier protein bound fatty acids during the first step of biotin biosynthesis in Bacillus subtilis (1) . Additional examples are found in the biosynthesis of the vancomycin type antibiotics: balhimycin (10), chloroeremomycin (11) and vancomycin, produced by a different strains of Amycolatopsis ( Fig. 1) (12, 13) . In the biosyntheses of these compounds, the P450s OxyA, OxyB and OxyC have been shown in vivo to be responsible for the oxidative phenolic coupling of the aromatic side chains found in the vancomycin aglycone (14) (15) (16) (17) (18) . The role of the fourth P450 in the vancomycin gene cluster, OxyD, has been investigated in vivo, where it has been shown to be involved in the biosynthesis of L--R-hydroxytyrosine (L-3-Rhydroxytyrosine), an essential precursor in the biosynthesis of the vancomycin aglycone (19, 20) . OxyD has been shown to be transcribed along with two other genes, the first a non-ribosomal peptide synthase (BpsD), composed of single adenylation (A) and carrier protein (PCP) domains (21) , whilst the second (Bhp) was originally annotated as a perhydrolase (20) but was recently shown to be a thioesterase (TE) (22) . The likely roles for the three proteins can be inferred from the biosynthetic operons of other natural products which catalyze the formation of oxidized amino acids (23, 24) : firstly tyrosine is selectively loaded onto the PCP domain of BpsD, which serves as a substrate for OxyD hydroxylation of tyrosine, followed in turn by thioester cleavage of -R-hydroxytyrosine from BpsD by Bhp (Scheme 1). Biochemical characterization of the P450s that catalyze the oxidation of carrier protein bound amino acids in novobiocin and nikkomycin biosynthesis has been performed (23, 25) . Walsh and co-workers demonstrated that the oxidation of tyrosine to -R-hydroxytyrosine is catalyzed by the P450 NovI, with tyrosine bound to another protein in the novobiocin biosynthetic operon, NovH. NovH resembles an non-ribosomal peptide synthase (NRPS), possessing an adenylation and a carrier protein domain and which displays a high degree of selectivity for L-tyrosine activation (24) .Other aminocoumarin containing antibiotics have had similar NRPS and P450 genes identified within the biosynthetic operons encoding their production, including those of clorobiocin (P450: cloI, NRPS: cloH) (26) , simocyclinone (P450: simD1, NRPS: simD6) (27) and coumermycin A1 (P450: cumC, NRPS: cumD) (28) . In the case of nikkomycin biosynthesis, the activation of a histidine residue by the NRPS NikP1 allows the oxidation of the bound histidine residue to-Rhydroxyhistidine by the Cytochrome P450 NikQ. Removal of -R-hydroxyhistidine from NikP1 is then accomplished by NikP2, a thioesterase domain like protein (23) . The apparent similarities of the mechanisms for -hydroxyamino acid formation in these disparate classes of medicinally important compounds led to our interest in structurally characterizing the OxyD protein from Amycolatopsis mediterranei and to investigate the interaction between the P450 and its carrier protein bound substrate. Here we describe the expression and purification of the OxyD protein from A. mediterranei, its interaction with tyrosine presented in a peptidyl carrier protein domain bound form and describe the crystal structure of OxyD to 2.1 Å resolution, the first structure of a P450 involved in the oxidation of an amino-acid charged carrier protein to be determined. We have identified a common motif present in all known P450s thatcatalyze carrier protein bound -hydroxyamino acid formation and visualized this binding interface upon the OxyD structure. This now allows the sequence based identification of P450s involved in carrier protein bound amino-acid hydroxylation and also provides a platform for future rational redesign of a wide range of medicinally important biomolecules.
incorporation of unique 5'-NdeI and 3'-HindIII restriction sites. The genes were codon optimized for E. coli expression and supplied in pBluescript II plasmids. The genes were subjected to a restriction digest using NdeI and HindIII, purified by agarose gel electrophoresis and cloned into the corresponding sites in the E. coli expression plasmid pET28a(+) (Novagen, Darmstadt, Germany) such that the expression of the genes was placed under the control of a T7 promoter. In these constructs the expressed protein includes an N-terminal hexahistidine tag and thrombin cleavage site. The resulting clones, pOxyD and pBpsD_PCP, were sequenced through their reading frames. Plasmids were then used to transform chemically competent BL21(DE3)pLysS E. coli cells. A truncated construct (bpsD_spcp) encoding for residues 502 to 581 of the non-ribosomal peptide synthase BpsD from Amycolatopsis mediterranei was amplified from plasmid pBpsD_PCP using oligonucleotides sPCP_D1 GGTCGTCATATGA GCGGTCGTGCACCG and sPCP_D2 GCGG CCGCAAGCTTTTATTAGGTCAGTGC to introduce an 5'-NdeI restriction site and maintain the 3'-HindIII restriction site (underlined). The clone pBpsD_sPCP was then prepared as indicated above and used to transform chemically competent BL21(DE3) E. coli cells. A synthetic gene encoding a hybrid construct of the C-terminal region of the non-ribosomal peptide synthase BpsD (amino acids 502 to 581) from Amycolatopsis mediterranei along with the first 14 residues replaced with MEKAPENETEKVLS (the first -helix from the soluble published PCP_7S construct from Amycolatopsis orientalis (29) , conserved residues underlined) was obtained from Geneart with concomitant incorporation of unique 5'-NdeI and 3'-HindIII restriction sites and an Nterminal start codon. The gene was codon optimized for E. coli expression and supplied in the plasmid pMA. The clone pBpsD_hPCP was then prepared as indicated above and used to transform chemically competent BL21(DE3) E. coli cells. Cloning of the bpsD_pcp domain as N-terminal fusion proteins-The hybrid construct bpsD_hpcp was amplified from plasmid pBpsD_hPCP using oligonucleotides sPCP_D3 AATTACCATGGGC GGTCGTGCACCGAGC and sPCP_D4 GGATCTCAGTGGTGGTGG to introduce a 5'-NcoI restriction site and retain the 3'-NotI restriction site present in the construct pBpsD_hPCP for expression screening with a fusion-protein vector series (30) . The bpsD_hpcp gene thus amplified was subjected to a restriction digest using NcoI and NotI, purified by agarose gel electrophoresis and cloned into the corresponding sites in the E. coli N-terminal fusion protein expression plasmid series reported by Bogomolovas et. al. (30) ; each construct bears an internal hexahistidine tag and a Tobacco Etch Virus protease cleavage site between the fusion protein and the cloned protein, with protein expression under the control of the T7 promoter. Single clones from each fusion protein construct were sequenced through the bpsD_hpcp reading frame to ensure that its sequence was without mutations before these clones were used to transform chemically competent BL21(DE3) E. coli cells. The plasmid identified as the best after test expression analysis (vide infra) was derived from plasmid pET-Trx_1b, encoding a thioredoxin fusion protein and is known as pTrxBpsD_hPCP_1b. To alter the position of the hexahistidine tag from in between the fusion domains (plasmid 1b) to at the C-terminus of the BpsD PCP domain (plasmid 1c), the hybrid construct bpsD_hpcp was amplified from plasmid pBpsD_hPCP using oligonucleotides sPCP_D5 TAGATCGCCCATGGAGAAAGCGCCGGAAA ACG and sPCP_D6 TGAATCTCGAGGGTC AGTGCTGCATCCAGAAC to introduce a 5'-NcoI restriction site and a 3'-XhoI restriction site (underlined) without a stop codon. The bpsD_hpcp gene thus amplified was subjected to a restriction digest using NcoI and XhoI, purified by agarose gel electrophoresis and cloned into the corresponding sites in the E. coli fusion protein expression plasmid pET-Trx_1c, with this construct bearing a C-terminal hexahistidine tag following the cloned protein sequence TrxBpsD_hPCP and protein expression under the control of the T7 promoter (30) . The resultant clone, pTrx-BpsD_hPCP_1c, was sequenced through the bpsD_hpcp reading frame to ensure that its sequence was without mutations. Plasmid pTrx-BpsD_hPCP_1c was then used to transform chemically competent BL21(DE3) E. coli cells. 4 0.2 micron filter and degassed prior to use. The determination of protein concentration was performed using the method of Bradford using BSA as a reference protein (31) . OxyD Expression and Purification-pOxyD transformed BL21(DE3)pLysS cells were grown overnight at 37 ºC in TB + kanamycin (25 mg/ L) to provide a starter culture for expression. 5 x 2 L of TB + kanamycin (25 mg/ L) was then inoculated with 1% (v/v) of overnight culture and grown at 37 ºC to an absorbance (600 nm) of 0.5, whereupon the temperature was reduced to 18 ºC and 0.5 mM -aminolevulinic acid was added. Expression of OxyD was induced 20 minutes later using 0.1 mM IPTG. After 24 hours at 18 ºC, a further 0.5 mM of -aminolevulinic acid was added to the cultures, which were then grown for a further 24 hours. The cell pellet was collected by centrifugation at 4 ºC (5000x g) and resuspended in lysis buffer (50 mM Tris.HCl (pH 7.4), 50 mM NaCl, 1 mM PMSF, 0.5 mM DTE). The cells were lysed using two passes through a fluidizer (Microfluidics, Newton, MA). The lysis solution was clarified by centrifugation (120000x g) and loaded onto a 5 mL Ni-NTA Superflow column (Qiagen, Hilden, Germany) that had been preequilibrated in Ni-wash buffer (50 mM Tris.HCl (pH 8.0), 300 mM NaCl and 20 mM imidazole). The column was washed with 5 column volumes (CV) of Ni-wash buffer before the bound protein was eluted with 1.5 CV of Ni-elution buffer (50 mM Tris.HCl (pH 8.0), 300 mM NaCl and 250 mM imidazole). The eluted fractions were concentrated and buffer exchanged into QA-buffer (50 mM Tris.HCl (pH 8.0), 50 mM NaCl and 0.5 mM EDTA) using NAP-25 columns (GE Healthcare, Munich, Germany). The protein was purified by anion exchange chromatography using a MonoQ column (GE Healthcare, Munich, Germany) attached to an Äkta FPLC (GE Healthcare, Munich, Germany). Following loading, the column was washed with 8 CV of QA buffer before the bound protein was eluted with a 15 column volume gradient with a final concentration of 40% 50 mM Tris.HCl (pH 8.0), 1 M NaCl and 0.5 mM EDTA. The eluted fractions were analyzed by SDS-PAGE, appropriate fractions pooled, concentrated and subjected to gel filtration on a Superose-12 column (GE Healthcare, Munich, Germany) attached to an Äkta FPLC using exchange buffer (50 mM Tris.HCl (pH 8.0), 100 mM NaCl). The eluted fractions were analyzed by SDS-PAGE, appropriate fractions pooled, concentrated using an Amicon Ultra centrifugal filter with a 30,000 MW cut-off (Millipore, Bedford, MA) and aliquots flash frozen in liquid nitrogen and stored at -80C. Final protein yield of OxyD from the 10 L of culture was 20 mg. The identity of the purified protein as OxyD was confirmed by MALDI-TOF MS peptide map fingerprinting of a tryptic digest of the excised SDS-PAGE protein band. Attempted Expression of BpsD_PCP ConstructsAppropriately transformed BL21(DE3) cells were grown overnight at 37 ºC in TB + kanamycin (25 mg/ L) to provide a starter culture for expression. 50 mL test cultures of TB + kanamycin (25 mg/ L) were inoculated with 1% (v/v) of overnight culture and grown at 37 ºC to an absorbance (600 nm) of 0.5, whereupon the temperature was reduced to 18 ºC. Expression of the PCP_D construct was induced 10 minutes later using 0.1 mM IPTG. After 24 hours the cell pellet was collected by centrifugation at 4 ºC (5000x g), the pellet resuspended in lysis buffer, and the cells lysed using sonication. The lysis solution was clarified by centrifugation (120000x g), with the whole cell, soluble and insoluble protein fractions analyzed by SDS-PAGE. No construct tested afforded any overexpression of BpsD_PCP protein.
Test Expression of pET-Fusion BpsD_PCP Constructs-
Appropriately transformed BL21(DE3) cells were grown overnight at 37 ºC in TB + kanamycin (25 mg/ L) to provide a starter culture for expression of each fusion protein. 50 mL test cultures of TB + kanamycin (25 mg/ L) were inoculated with 1% (v/v) of overnight culture and grown at 37 ºC to an absorbance (600 nm) of 0.5, whereupon the temperature was reduced to 18 ºC. Expression of the PCP_D construct was induced 10 minutes later using 0.1 mM IPTG. After 12 hours the cell pellet was collected by centrifugation at 4 ºC (5000x g), the pellet resuspended in lysis buffer, and the cells lysed using sonication. The lysis solution was clarified by centrifugation (120000x g), with the whole cell, soluble and insoluble protein fractions analyzed by SDS-PAGE. All N-terminal fusion protein constructs (see (30) ) afforded overexpression of BpsD_PCP fusion proteins, although not all resulted in the production of soluble protein. The identity of all fusion proteins were confirmed by MALDI-TOF MS peptide map fingerprinting of tryptic digests of the excised SDS-PAGE protein bands corresponding to each individual fusion protein.
Expression of and Purification of pTrxBpsD_hPCP_1b
ConstructAppropriately transformed BL21(DE3) cells were grown overnight at 37 ºC in TB + kanamycin (25 mg/ L) to provide a starter culture for expression. 2 x 1 L cultures of TB + kanamycin (25 mg/ L) were inoculated with 1% (v/v) of overnight culture and grown at 37 ºC to an absorbance (600 nm) of 0.4, whereupon the temperature was reduced to 18 ºC. Expression of the Trx-PCP_D_1b construct was induced 15 minutes later using 0.1 mM IPTG. After 12 hours the cell pellet was collected by centrifugation at 4 ºC (5000x g), the pellet resuspended in lysis buffer and the cells lysed using sonication. The lysis solution was clarified by centrifugation (120000x g) and loaded onto a 1 mL Ni-NTA Superflow column that had been preequilibrated in Ni-wash buffer. The column was washed with 5 CV of Ni-wash buffer before the bound protein was eluted with 1.5 CV of Nielution buffer. SDS-PAGE analysis of the eluted protein revealed large amounts of thioredoxin protein without the BpsD_PCP fusion. The identity of both the full length and truncated proteins was confirmed by MALDI-TOF MS peptide map fingerprinting of tryptic digests of the excised SDS-PAGE protein bands. Due to proteolytic cleavage, the decision was made to switch to a Cterminal hexahistidine tag fusion protein to avoid co-purification of truncated fusion proteins along with the desired full length construct.
Expression of and Purification of pTrxBpsD_hPCP_1c
ConstructAppropriately transformed BL21(DE3) cells were grown overnight at 37 ºC in TB + kanamycin (25 mg/ L) to provide a starter culture for expression. 10 x 100 mL cultures of TB + kanamycin (25 mg/ L) were inoculated with 1% (v/v) of overnight culture and grown at 37 ºC to an absorbance (600 nm) of 0.4, whereupon the temperature was reduced to 18 ºC. Expression of the Trx-PCP_D_1c construct was induced 15 minutes later using 0.1 mM IPTG. After 12 hours the cell pellet was collected by centrifugation at 4 ºC (5000x g), the pellet resuspended in lysis buffer and the cells lysed using sonication. The lysis solution was clarified by centrifugation (120000x g) and loaded onto a 1 mL Ni-NTA Superflow column that had been preequilibrated in Ni-wash buffer. The column was washed with 5 CV of Ni-wash buffer before the bound protein was eluted with 1.5 CV of Nielution buffer. SDS-PAGE analysis of the eluted protein revealed > 95% pure full-length protein, which was buffer exchanged against exchange buffer, concentrated using an Amicon Ultra centrifugal filter with a 5000 MW cut-off divided into aliquots and flash frozen in liquid nitrogen before being stored at -80°C. The identity of the purified protein as Trx-BpsD_PCP was confirmed by MALDI-TOF MS peptide map fingerprinting of a tryptic digest of the excised SDS-PAGE protein band. (47) . Structure-based sequence alignments were carried out with SSM (48) as implemented in COOT, with secondary structure analysis of the final structure performed using the DSSPcont server (49) and comparisons to known structures performed using DaliLite (50) . Electrostatic properties were calculated using the program APBS (51) as implemented in PyMol (52) . All structural figures were prepared using PyMol (52) . Sequence Alignments and Homology ModelingSequence alignments were performed using the ClustalW2 server at EMBL-EBI (53) . Similar sequences were determined using BLAST (54) as implemented by the Expasy Proteomics Server (55). Secondary structure prediction was performed using the Jpred3 server (56) .
Synthesis of Amino Acid Derivatives and PCP Modification Synthesis of N-acetylcysteamine (SNAc) and

Generation of BpsD PCP Domain
Model-A homology model of the BpsD PCP domain was generated from the known structure of a PCP from the tyrocidine A NRPS (PDB code 2JGP)(57) using SWISS-MODEL (58); this template structure was chosen as it contains the closest related PCP domain to the BpsD PCP domain with a crystal structure available in the PDB. The PCP model thus generated was docked onto the structure of OxyD using the program HEX 4.2 (59). Two of the docking solutions afforded possible binding orientations in terms of geometry and distance of the postranslationally modified serine reside to the heme iron. Similar conformations were observed with the docking of the apo-PCP molecule onto OxyD using the programs Patchdock (60) and Gramm (61) .
RESULTS
OxyD Protein Expression-P450 OxyD was successfully overexpressed in BL21(DE3)pLysS cells, affording soluble protein (2 mg/L expression culture) following cell lysis and clarification, albeit with high levels of protein expression resulting in inclusion bodies. An initial Ni-NTA affinity purification of the clarified cell lysate was followed by anion exchange to remove minor contaminants, whilst a final gel filtration step was employed both as a final polishing step and to buffer exchange the protein prior to storage at -80ºC. The final protein purity, expressed as the absorbance of the heme soret divided by the absorbance of aromatic residues at 280 nm was found to be 1. Fig. 2A, SI Fig.  1 ). There was no difference in affinity for the (L)-tyrosine loaded Trx-BpsD_PCP (13  4 M) compared to the (L)-phenylalanine loaded protein (14  2 M), although there was a decrease in the percentage spin state shift from 40% for (L)-tyrosine loaded Trx-BpsD_PCP to 31% for (L)-phenylalanine loaded Trx-BpsD_PCP. Additionally, and as expected, the binding of holo Trx-BpsD_PCP (including the CoA derived linker but not the bound amino acid) to OxyD revealed no spin state shift upon increasing concentrations of the substrate. In all cases, the use of the fusion protein was necessary due to the instability of the isolated PCP domain. These results are consistent with those obtained for the binding of PCP-loaded peptides by OxyB, in terms of both spin state change and dissociation constant (17  5 M) (29) . They also indicate that only a fraction of the OxyD molecules are able to bind at any one point in time to the PCP-loaded substrates. The use of amino acid N-acetylcysteamine thioesters (SNAc thioesters) as substrate analogues for investigating non-ribosomal peptide synthases and biosynthetically related proteins is well established (22, 32, 33) , with the advantage of much simpler substrate preparation and product analysis. The use of amino acid SNAc thioesters for binding studies with OxyD was therefore attempted. However, in this case the behavior of these substrates does not a mimic tyrosyl-PCP binding to OxyD. A comparable situation regarding the appropriateness of SNAc thioesters for amino-acyl PCP P450 oxidases has been observed with NovI, whereby L-Tyrosine SNAc was not hydroxylated by NovI (24) . L-Tyrosine SNAc binds to OxyD in a cooperative manner (with a Hill constant (n) of 3  0.2), with a K a of 11  1 M and a high percentage spin state shift (92%) (Fig. 2B) . The binding of L-Phenylalanine SNAc to OxyD displays similar behavior (K a of 12  1 M), with a high Hill constant (n = 4  0.8) and a high percentage spin state shift (75%). The binding of these small molecules thus does not represent a good model for PCP-loaded substrate binding to OxyD. Additionally, qualitative analysis of (D)-tyrosine SNAc, (L)-tyrosine CoA and (L)-phenylalalanine CoA binding to OxyD also reveals cooperative behavior (data not shown). These results indicate that the complete PCP binding partner is necessary to obtain relevant binding data for OxyD substrates. Overall Structure of OxyD-The structure of OxyD adopts the canonical P450 fold, with predominantly -helical secondary structure surrounding a non-covalently linked heme (protoporphyrin IX) moiety (Fig. 3) . In total there are 14 -helices bearing the designations A'-L and 3 -sheets bearing the designations -1 to -3. The two OxyD monomers (A and B) in the asymmetric unit of the unit cell are structurally very similar (root mean square deviation (RMSD) of 0.4 Å for C atoms). Active Site Architecture-The active site of OxyD contains the conserved catalytic residues and typical structure found in P450s, which includes a kink in the I-helix where the highly conserved acid/alcohol residue pair (Glu-238/ Thr-239 in OxyD) controls the protonation of intermediate oxygen species during oxygen activation (Fig. 4A ) (62) . There is a water molecule bound to the heme iron at a distance of 2.0 Å and at least one glycerol molecule is also present in the active site of OxyD (Fig. 4A) . The glycerol molecules are in similar conformations in the two monomers of the asymmetric unit, with an oxygen atom the closest atom to the heme iron (4.3 Å and 4.4 Å for chain A and B, respectively) and hydrogen bonding to the heme-bound water (2.8 Å and 3.0 Å for chain A and B, respectively). The active site is composed of several structural elements, one of them being the N-terminal and central regions of the I-helix (residues 228 -239), which extends across the face of the heme. The opposite side of the heme is enclosed by a -strand and the immediately preceding residues (residues 281 -287), which form part of the -1 sheet. Above this beginning of the -strand, residues Val-382 and Val-383 from the long C-terminal loop impinge upon the active site, whilst the opposite side of the active site, containing the heme propionate groups, is formed by the N-and Cterminal portions of the B-B 2 loop (in total residues 69 -88). The active site is rather open above the heme, with the C-terminal residues of the F-helix and the N-terminal residues of the Ghelix forming a cap above the I-helix (residues 171 -188). The long loop between the F and G helices is pushed away from the top of the active site, where it forms crystal contacts with the first -strand in the -1 sheet of another OxyD molecule. It is possible that this region closes upon substrate binding to the P450, whilst the conformation adopted by the central portion of the B-B 2 loop may also rearrange upon substrate binding. The observed active site geometry is enforced by a number of inter-residue hydrogen bonds that hold the secondary structure elements in their given conformation (Fig. 4B) . These include the interactions of the F and G helices with the I-helix, mediated through the interaction of the backbone carbonyl of the F-helix residue Asn-169 with the guanidine nitrogen atom of the I-helix residue Arg-241 (2.7 Å) and through the interaction of a histidine nitrogen atom of the G-helix residue His-188 with the carboxylate group of the I-helix residue Asp-230 (2.7 Å). The C-terminal portion of the B-B 2 loop interacts with the I-helix through hydrogen bonds between the backbone amide nitrogen atoms of Met-87 and Val-88 and the carbonyl side chain oxygens of the I-helix residues Asn-228 and Asn-231 (2.9 Å and 3.0 Å, respectively) (Fig. 4B) . The -1 strand residue His-284 forms interactions with two other secondary structure elements in close proximity to the heme. These interactions are mediated by hydrogen bonding between the histidine side chain nitrogen atoms and the backbone nitrogen and carbonyl oxygen atoms of residues Ile-381 and Ile-72 (2.7 Å and 3.0 Å, respectively). The interaction with Ile-72 also makes it more likely that this section of loop containing the non-polar residues Met-Met-Ile runs across the top of the -1 strand even after the binding of the PCP-bound substrate. Structural Comparisons to Other P450s-Analysis of the closest related P450 structures to OxyD that are present in the PDB was performed on a sequence level using BLAST and on a structural level using the DALI server. The two approaches produced essentially the same list of ten P450s with similarity to OxyD. OxyD shares the highest structural similarity with CYP124 and CYP125 from Mycobacterium tuberculosis (PDB code for CYP124 2WM4, RMSD (C) 2.4 Å (63); PDB code for CYP125 3IW0, RMSD (C) 2.4 Å (64)), although several other P450 structures also share similar RMSD (C) values (SI Table 1 ). Overall, the most significant differences between these structures and that of OxyD include the substrate recognition sites (SRSs) (65): the B-B 2 loop region, the relative orientation of the F-and Ghelices to the B-B 2 region, the "open" nature of the loop connecting the F-G helices and alterations in the length and orientations of loop extensions of the first loop in the -1 sheet (SI Fig. 2) . Alignments with other amino acid PCP oxidizing P450s-Individual sequence alignments of OxyD with seven other tyrosyl-PCP, tryptophanyl-PCP, histidinyl-PCP and valyl-PCP oxidizing P450s was performed, revealing an average sequence identity of 35% and an average sequence similarity of 50% (SI Table 2 ). In addition to the conserved P450 heme binding motif, regions of high conservation were identified that occur in the P450 SRSs (65). With the ability to localize these areas upon the OxyD structure, concentrations of conserved residues can be seen occurring towards the surface opening of the active site and in the active site itself (Fig. 5) . In particular, these regions include the N-and C-termini of the B-B 2 loop (Gly-69, Ile-72; Ser-82, Gly-83, Gly-84, Met-86, Val-89, Ser-90), the C-terminal region of the F-helix (His-171, Ala-172, Phe-173, Gly-174), the N-terminal region of the G-helix (Ala-187, His-188, Thr-189, , the N-terminal region of the active site I-helix (Asn-228, Cys-229, Gly-235), and the -1 sheet adjacent to the heme (Ala-282, Met-283, His-284) ( Table 3) . Four of these residues correspond to residues involved in maintaining the relative geometry of the secondary structural elements (Fig. 4B) , with the rest in the correct position for either interaction with the PCP or forming the active site around the bound substrate. Alignment of these 23 residues amongst the sequences of the PCP-oxidizing P450s revealed a very high degree of conservation of these residues, with very few altered to noncomparable chemistries (17 such mutations across 230 total residues). Most differences from the consensus sequence are seen in the sequence of the valine oxidizing P450 ZbmVIIc, which is somewhat unsurprising given that this substrate is also most distinct from the others analyzed here. Alignment of the ten most similar structures to OxyD, none of which catalyze the oxidation of aminoacyl-PCPs but three of which have carrier protein bound substrates, indicated that the particular sequence regions indicated above are able to distinguish P450s that interact with PCPbound amino acid substrates compared to other substrates (SI Table 3 ). Of the 23 residues identified above, a maximum of 7 similar residues were present in one sequence (that of CYP130), whilst the majority of sequences shared only 2-4 similarities.
Alignment and Modeling of PCP-domains that
Interact with Amino Acid Oxidizing P450s-Alignment of the PCP domains from NovH, NikQ, ZmbVIIb and Ecm12 were made with the PCP domain from BpsD. All sequences exhibit around 40% sequence identity and 50-60% similarity upon alignment, with the predicted secondary structure elements also matching well (SI Table 4 ). The sequence similarity around the post-translationally modified serine residue at the beginning of the predicted helix -2 is the highest, as this region exhibits the motif required for phosphopantetheinyl-transferases (PPTases) to convert the apo-PCP domains into the phosphopantetheine modified holo forms. Allowing for single amino acid miss-alignments per residue in a five-way sequence alignment, the region of highest conservation not including the PPTase motif is the C-terminal portion of helix -2, followed by the C-terminal region of the -1 helix and the short helix -3. The majority of the conserved regions in -1 and -4 are predicted to project into the hydrophobic pocket between the helices, indicating that the potential interaction interface of the PCPs is centered on the -2 helix and possibly extending to include the -3 helix. Docking studies of a homology modeled BpsD PCP domain afford two possible docking solutions where the post-translationally modified serine residue is within 20 Å of the heme iron (Fig. 6 ). Both these solutions indicate a preferential binding for the apo-PCP in the junction of the C-terminus of the I-helix and the G-helix of OxyD, although it must be stressed that this docking does not explore the potential structural rearrangement of the OxyD structure upon interaction with the tyrosyl-PCP and as such acts merely as a guide to future interaction studies between the PCP and OxyD. It does however indicate an interface involving helices -2 to -3, which appears feasible given the sequence alignment analysis. The surface charge distribution of OxyD indicates that the active site of OxyD is predominantly negatively charged, with the exception of one residue in the G-helix (Arg-185), whilst the docked PCP structures are both oriented in such a way as to present a large patch of positive charge at the potential docking interface (Fig. 7) .
DISCUSSION
OxyD binds PCP-bound amino acid substrates-
The binding of substrates to P450 OxyD has been investigated by monitoring the changes in heme environment upon substrate binding to the P450. This indicates that binding of amino acids to OxyD does not occur unless the BpsD PCP domain and prosthetic phosphopantetheine linker are attached to the amino acid. This is understandable in biosynthetic terms, as this then allows the diversion of amino acids into secondary metabolism to be more tightly controlled without the indiscriminate oxidation of amino acids otherwise required for protein biosynthesis. The presence of the PCP domain and linker is a major determinant in binding selectivity for OxyD, with either phenylalanine of tyrosine loaded PCPs exhibiting similar binding efficiency to OxyD.
Identification of a common motif in P450s
oxidizing amino acid-bound PCPs-Sequence alignments of seven P450s with similar substrates to OxyD have revealed 23 highly conserved residues across six different regions of the structure, which correspond to the substrate recognition sites (SRSs) in P450s (65). These regions of similarity within the amino acid-bound PCP oxidizing P450s may be used in distinguishing these P450s from P450s catalyzing the oxidation of other substrates. The lowest internal agreement for any amino acid-bound PCP oxidizing P450 with the common sequence identified for the 23 highly conserved residues was 70% for ZmbVIIc, which despite the different nature of the amino acid substrate in this case (valine) still exhibits a high level of sequence identity. The degree of conservation of the 23 "fingerprint" residues that aminoacyl-PCP binding P450s display compared to P450s catalyzing different oxidative transformations is low, allowing these regions to be used to differentiate amino acidbound PCP oxidizing P450s from P450s catalyzing the oxidation of different substrates. The highest similarity found comparing the conserved amino acid-bound PCP oxidizing P450 sequence to that of a P450 with a different substrate is 30% (CYP130), a figure close to the sequence identity for the protein as a whole (27%). All other structurally similar proteins gave lower similarity in matches to the regions of similarity identified within the amino acid-bound PCP oxidizing P450s than their overall sequence identity with OxyD. The regions identified as highly conserved in the amino acid-bound PCP oxidizing P450s are appropriately placed around the active site to suggest that they represent a common binding motif for these proteins, and help to present a binding surface almost exclusively dominated by negative charges. The oxidative selectivity normally built into the active sites of P450s is reduced in the case of PCP-bound substrates, firstly due to the PCP carrier molecule and prosthetic linker presenting a large binding surface for recognition and secondly due to the nature of the upstream processes that lead to the loading of the PCP domain of the non-ribosomal peptide synthase that acts as the P450 substrate. The selectivity of the adenylation domains of NRPSs for selecting one amino acid is very high, thus reducing the need for the P450 to select the correct amino acid through a highly optimized active site. This lowered selectivity is seen in the equivalent binding of PCPs to OxyD loaded with either phenylalanine of tyrosine, and explains the apparent lack of coordinating residues for the tyrosine phenol group within the active site. This does however lead to the situation that the PCP becomes the major determining factor in substrate binding to amino acid-bound PCP oxidizing P450s. Identification of P450 function from primary sequence analysis-The identification of common motifs in PCP-bound amino acid P450 oxidases suggests that analysis of primary sequence data can reveal whether the substrate for a P450 is an amino acyl-PCP. Using this type of analysis, it would appear that CYP185A1 (CypLB) from Streptomyces tubercidicus I-1529 (66) encodes an amino acyl-PCP oxidase (Table 3) . This hypothesis is supported by the presence of an upstream non-ribosomal peptide synthase and a downstream isolated thioesterase domain, in a similar arrangement to that seen with OxyD. Unfortunately, the sequence of the adenylation domain of the upstream NRPS was not included in the submitted sequence data, making the exact nature of the amino acid substrate unclear. It would appear, however, that based upon the sequence analysis and the surrounding genes that CYP185A1 is a PCP amino acid hydroxylase. The determination of P450 substrate based upon analysis of the protein sequence has been attempted for many P450s with only limited success, unless there is high sequence similarity to a P450 of known function. The ability to assign PCP-bound amino acid oxidation to a P450 based upon the identified sequence motifs constitutes a powerful tool in the future analysis and discovery of new biomolecules. Interaction of the PCP domain with OxyD-Given the importance of the role of the PCP domain in substrate binding to amino acid-bound PCP oxidizing P450s, it would be expected that the similar binding surfaces formed by these P450s would require PCP domains to possess high degrees of similarity -in fact, the similarity of the PCP domains in the systems discussed here is over 50% in all cases, and is often much higher (SI Table 4 ). The alignment of predicted secondary structure matches more than 90% in all cases, with the greatest sequence conservation centered on the long -2 helix (the post-translationally modified serine is found in a loop prior to the -2 helix). The surface charge distributions of the PCP models indicate an overall positive charge across the surface of the PCP formed by the -2 and -3 helices, complementary to the overall negative charge seen on the OxyD binding surface. Docking a model of the apo-PCP with Hex onto OxyD affords two favorable binding conformations, where these regions of complementary charge interact (Fig. 7) . Crucially, these possible arrangements present the post-translationally modified serine residue closer to the active site heme than that seen in the case of P450 BioI , an arrangement made necessary by the fact that in P450 BioI the sites of oxidation in the fatty acid substrate (C7 and C8 of the fatty acid chain) are approximately 9.1 Å from the thioester linkage with the ACP phosphopantetheine linker. In the case of OxyD, however, the substrate is a PCPbound tyrosine residue, where the distance from the tyrosine -carbon to the thioester linkage of the PCP phosphopantetheine linker is only 4.1 Å. This implies a much more intimate binding of the two proteins, with the PCP having to reside closer to the active site of OxyD. It must be stressed, however that the docked models do not reflect the potential for rearrangement of the OxyD protein upon PCP binding. The docked models are however consistent with a wider opening of the active site of OxyD to accommodate the PCP binding partner. IPTG, isopropyl β-D-1-thiogalactopyranoside; CV, column volumes; SDS-PAGE, sodium dodecylsulfate polyacrylimide gel electrophoresis; Trx, thioredoxin; MALDI-TOF MS, matrixassisted laser desorption/ ionisation-time of flight mass spectrometry; SNAc, N-acetylcysteamine; TFA, trifluoroacetic acid; SRS, substrate recognition site; PPTase, phosphopantetheinyl transferase. Table 1 . Spectroscopic determination of substrate binding to OxyD.
Conclusions-
TABLES
Substrate
Binding Mode 
(a) Identity residues are emboldened and underlined, 1-2 mismatching residues or similar residues indicated in normal font. Exceptions are: (1) Small residue (S, G, A), (2) Positively Charged Residue (K, H, R), (3) Majority Hydrophobic (L, V; also S and G), (4) Majority Small (S, A; also V). (b) Percentage of residues matching to the overall consensus rule, based upon similarity. Fig. 1 . Structures of medicinally important natural products derived from -hydroxyamino acid residues (groups derived from the -hydroxyamino acids shown in red; novobiocin and clorobiocin also possess an additional moiety derived from a -hydroxytyrosine, shown in blue). A. Active site of OxyD showing critical P450 catalytic residues and those interacting with the heme propionate groups, with hydrogen bonding distances indicated (critical catalytic residues shown in magenta, heme interacting residues shown in blue, heme-bound water shown in green, glycerol molecules shown in yellow, heme shown in orange, OxyD shown in grey). B. Hydrogen bonding interactions between residues from different structural elements controlling the geometry of the active site pocket, with hydrogen bonding distances indicated (F or G-helix residues shown in yellow, I-helix residues shown in cyan, B-B 2 loop residues shown in magenta, 1-sheet residues shown in green, C-terminal loop residues shown in orange, heme shown in red, OxyD shown in grey). Fig. 5 . Conserved residues found in the alignment of PCP-bound amino acid P450s localized on the structure of OxyD (B-B 2 loop residues shown in magenta, F-helix residues shown in orange, G-helix residues shown in yellow, I-helix residues shown in cyan, -1 sheet residues shown in green, heme shown in dark grey, OxyD shown in grey with secondary structure elements labeled). 
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N E (a) Identity residues are emboldened and underlined, 1-2 mismatching residues or similar residues indicated in normal font. Exceptions are: (1) Small residue (S, G, A), (2) Positively Charged Residue (K, H, R), (3) Majority Hydrophobic (L, V; also S and G), (4) Majority Small (S, A; also V).
(b) Percentage of residues matching to the overall consensus rule, based upon similarity.
